Literature DB >> 31104567

Proteasome-Dependent Regulation of Distinct Metabolic States During Long-Term Culture of Human iPSC-Derived Cardiomyocytes.

Antje Ebert1,2,3, Amit U Joshi4, Sandra Andorf5,6, Yuanyuan Dai1,2,3, Shrivatsan Sampathkumar1,2,3, Haodong Chen1,7, Yingxin Li1,7, Priyanka Garg1,7, Karl Toischer2,3, Gerd Hasenfuss2,3, Daria Mochly-Rosen4, Joseph C Wu1,7.   

Abstract

RATIONALE: The immature presentation of human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) is currently a challenge for their application in disease modeling, drug screening, and regenerative medicine. Long-term culture is known to achieve partial maturation of iPSC-CMs. However, little is known about the molecular signaling circuitries that govern functional changes, metabolic output, and cellular homeostasis during long-term culture of iPSC-CMs.
OBJECTIVE: We aimed to identify and characterize critical signaling events that control functional and metabolic transitions of cardiac cells during developmental progression, as recapitulated by long-term culture of iPSC-CMs. METHODS AND
RESULTS: We combined transcriptomic sequencing with pathway network mapping in iPSC-CMs that were cultured until a late time point, day 200, in comparison to a medium time point, day 90, and an early time point, day 30. Transcriptomic landscapes of long-term cultured iPSC-CMs allowed mapping of distinct metabolic stages during development of maturing iPSC-CMs. Temporally divergent control of mitochondrial metabolism was found to be regulated by cAMP/PKA (protein kinase A)- and proteasome-dependent signaling events. The PKA/proteasome-dependent signaling cascade was mediated downstream by Hsp90 (heat shock protein 90), which in turn modulated mitochondrial respiratory chain proteins and their metabolic output. During long-term culture, this circuitry was found to initiate upregulation of iPSC-CM metabolism, resulting in increased cell contractility that reached a maximum at the day 200 time point.
CONCLUSIONS: Our results reveal a PKA/proteasome- and Hsp90-dependent signaling pathway that regulates mitochondrial respiratory chain proteins and determines cardiomyocyte energy production and functional output. These findings provide deeper insight into signaling circuitries governing metabolic homeostasis in iPSC-CMs during developmental progression.

Entities:  

Keywords:  homeostasis; induced pluripotent stem cells; mitochondria; proteasome; regenerative medicine

Mesh:

Substances:

Year:  2019        PMID: 31104567      PMCID: PMC6613799          DOI: 10.1161/CIRCRESAHA.118.313973

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  48 in total

1.  Age-related decrease in resting energy expenditure in sedentary white women: effects of regional differences in lean and fat mass.

Authors:  G R Hunter; R L Weinsier; B A Gower; C Wetzstein
Journal:  Am J Clin Nutr       Date:  2001-02       Impact factor: 7.045

2.  Stochastic gene expression in a single cell.

Authors:  Michael B Elowitz; Arnold J Levine; Eric D Siggia; Peter S Swain
Journal:  Science       Date:  2002-08-16       Impact factor: 47.728

3.  Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach.

Authors:  Laura Sartiani; Esther Bettiol; Francesca Stillitano; Alessandro Mugelli; Elisabetta Cerbai; Marisa E Jaconi
Journal:  Stem Cells       Date:  2007-01-25       Impact factor: 6.277

4.  Genetic and environmental conditions that increase longevity in Caenorhabditis elegans decrease metabolic rate.

Authors:  W A Van Voorhies; S Ward
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

5.  Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts.

Authors:  Wolfram-Hubertus Zimmermann; Ivan Melnychenko; Gerald Wasmeier; Michael Didié; Hiroshi Naito; Uwe Nixdorff; Andreas Hess; Lubos Budinsky; Kay Brune; Bjela Michaelis; Stefan Dhein; Alexander Schwoerer; Heimo Ehmke; Thomas Eschenhagen
Journal:  Nat Med       Date:  2006-04-02       Impact factor: 53.440

6.  PKA rapidly enhances proteasome assembly and activity in in vivo canine hearts.

Authors:  Mitsutoshi Asai; Osamu Tsukamoto; Tetsuo Minamino; Hiroshi Asanuma; Masashi Fujita; Yoshihiro Asano; Hiroyuki Takahama; Hideyuki Sasaki; Shuichiro Higo; Masanori Asakura; Seiji Takashima; Masatsugu Hori; Masafumi Kitakaze
Journal:  J Mol Cell Cardiol       Date:  2008-11-13       Impact factor: 5.000

7.  Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome.

Authors:  Xonia Carvajal-Vergara; Ana Sevilla; Sunita L D'Souza; Yen-Sin Ang; Christoph Schaniel; Dung-Fang Lee; Lei Yang; Aaron D Kaplan; Eric D Adler; Roye Rozov; Yongchao Ge; Ninette Cohen; Lisa J Edelmann; Betty Chang; Avinash Waghray; Jie Su; Sherly Pardo; Klaske D Lichtenbelt; Marco Tartaglia; Bruce D Gelb; Ihor R Lemischka
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

8.  Hsp90-mediated assembly of the 26 S proteasome is involved in major histocompatibility complex class I antigen processing.

Authors:  Taketoshi Yamano; Shusaku Mizukami; Shigeo Murata; Tomoki Chiba; Keiji Tanaka; Heiichiro Udono
Journal:  J Biol Chem       Date:  2008-08-14       Impact factor: 5.157

9.  Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts.

Authors:  Michael A Laflamme; Kent Y Chen; Anna V Naumova; Veronica Muskheli; James A Fugate; Sarah K Dupras; Hans Reinecke; Chunhui Xu; Mohammad Hassanipour; Shailaja Police; Chris O'Sullivan; Lila Collins; Yinhong Chen; Elina Minami; Edward A Gill; Shuichi Ueno; Chun Yuan; Joseph Gold; Charles E Murry
Journal:  Nat Biotechnol       Date:  2007-08-26       Impact factor: 54.908

10.  Cardiomyocytes from human and mouse embryonic stem cells.

Authors:  Christine Mummery; Marcel A G van der Heyden; Teun P de Boer; Robert Passier; Dorien Ward; Stieneke van den Brink; Marga van Rooijen; Anja van de Stolpe
Journal:  Methods Mol Med       Date:  2007
View more
  21 in total

Review 1.  Cardiomyocyte Maturation-the Road is not Obstructed.

Authors:  Yaning Wang; Miao Yu; Kaili Hao; Wei Lei; Mingliang Tang; Shijun Hu
Journal:  Stem Cell Rev Rep       Date:  2022-07-05       Impact factor: 5.739

Review 2.  Deconvoluting the Cells of the Human Heart with iPSC Technology: Cell Types, Protocols, and Uses.

Authors:  Brian Yu; Shane Rui Zhao; Christopher D Yan; Mao Zhang; Joseph C Wu
Journal:  Curr Cardiol Rep       Date:  2022-03-04       Impact factor: 2.931

Review 3.  Induced pluripotent stem cells as a platform to understand patient-specific responses to opioids and anaesthetics.

Authors:  Detlef Obal; Joseph C Wu
Journal:  Br J Pharmacol       Date:  2020-08-27       Impact factor: 8.739

Review 4.  Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Preclinical Cancer Drug Cardiotoxicity Testing: A Scientific Statement From the American Heart Association.

Authors:  Gary Gintant; Paul Burridge; Lior Gepstein; Sian Harding; Todd Herron; Charles Hong; José Jalife; Joseph C Wu
Journal:  Circ Res       Date:  2019-09-19       Impact factor: 17.367

Review 5.  Human-induced pluripotent stem cells in cardiovascular research: current approaches in cardiac differentiation, maturation strategies, and scalable production.

Authors:  Dilip Thomas; Nathan J Cunningham; Sushma Shenoy; Joseph C Wu
Journal:  Cardiovasc Res       Date:  2022-01-07       Impact factor: 10.787

6.  Human iPSC-engineered cardiac tissue platform faithfully models important cardiac physiology.

Authors:  Willem J de Lange; Emily T Farrell; Caroline R Kreitzer; Derek R Jacobs; Di Lang; Alexey V Glukhov; J Carter Ralphe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-02-19       Impact factor: 4.733

Review 7.  Human-induced pluripotent stem cells as models for rare cardiovascular diseases: from evidence-based medicine to precision medicine.

Authors:  Ziwei Pan; Antje Ebert; Ping Liang
Journal:  Pflugers Arch       Date:  2020-11-18       Impact factor: 3.657

Review 8.  A Concise Review on Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Personalized Regenerative Medicine.

Authors:  Pallavi Pushp; Diogo E S Nogueira; Carlos A V Rodrigues; Frederico C Ferreira; Joaquim M S Cabral; Mukesh Kumar Gupta
Journal:  Stem Cell Rev Rep       Date:  2020-10-23       Impact factor: 5.739

Review 9.  Next generation of heart regenerative therapies: progress and promise of cardiac tissue engineering.

Authors:  Miguel F Tenreiro; Ana F Louro; Paula M Alves; Margarida Serra
Journal:  NPJ Regen Med       Date:  2021-06-01

10.  Mechanisms underlying diabetic cardiomyopathy: From pathophysiology to novel therapeutic targets.

Authors:  Shuo Cong; Chrishan J A Ramachandra; Kp Myu Mai Ja; Jonathan Yap; Winston Shim; Lai Wei; Derek J Hausenloy
Journal:  Cond Med       Date:  2020-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.